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INTRODUCTION 
[ have been asked numerous times why the cerebrospinal fluid (CSF) immunoglobu- 
lin-G (IgG) content has to be expressed as a percentage of the CSF total protein 
to be discriminative for multiple sclerosis (MS). From a historical standpoint, KABAT 
et al. (1950) found that the absolute value of CSF IgG (mg IgG/100 ml CSF) was 
elevated virtually every time when CSF total protein was significantly increased no 
matter which disease caused it; however, they discovered when the results were 
expressed as a ratio of the total protein, there emerged a pattern which discriminated 
MS from most other diseases. Eighty per cent of patients with MS had an elevated 
lgG value (IgG/total protein in ~)  > 13 ~ (mean + 2 standard deviations, P=  0.05). 
In subsequent reports by the same group, YAHR et al. (1954) and HARTER et al. (1962) 
found 67 and 73~ of patients with MS and neurosyphilis, respectively, had an 
elevated IgG value; whereas, only 5.5~ of 7225 patients who had a neurological 
disease other than a demyelinating disorder (MS, diffuse sclerosis, acute disseminated 
encephalomyelitis, and neuromyelitis optica) and neurosyphilis had an elevated value. 
It is not the purpose of this account to review in detail the incidence of abnormally 
elevated y-globulin quantitatively determined in CSF from MS patients reported by 
various investigators; TOURTELLOTTE (1970) has recently done this. In general the 
multitude of reports utilizing very different methods have confirmed the results 
presented by KASAT and his colleagues mentioned above obtained with the reliable 
and valid immunochemical method of KABAT et al. (1948). 
The quotients or ratios to be discussed are the following: IgG concentration ex- 
pressed as a percentage of the total protein concentration; IgG concentration ex- 
pressed as a percentage of the albumin concentration; igG concentration expressed 
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as a percentage of the fl-globulin concentration; and the CSF lgG concentration 
expressed as a percentage of the serum lgG concentration. 
it is the purpose of this review to disclose the basis for the discriminative value t\~r 
MS and the biologic significance of the various CSF IgG quotients by bringing to- 
gether all the relevant recent advances of CSF physiology and some new aspects of 
the pathology of M S. 
Finally, we will present a formula which estimates the amount of lgG, expressed in 
mg, synthesized per day by the central nervous system (CNS) of MS patients. This 
calculation can be considered to be a substitute for the previous lgG quotients proposed 
since the basis of these quotients to discriminate MS from most other diseases turns 
out to be a de novo  synthesis o f t gG  in the CNS of such cases. 
SINK ACTION OF THE CSF 
The CSF is unique among body fluids. This fluid not only fills the ventricles and 
surrounds the CNS but it also probably penetrates it by way of the Virchow-Robin 
spaces. Moreover, it is in close contact with but separated by a barrier from the blood 
supply of the CNS as well as from the blood and lymphatic supply of its covering 
membranes. TSCHIRGI (1960) was one of the first investigators to present some evidence 
to support the hypothesis that the CSF is a pool of circulating fluid in communication 
with the extracellular fluid (ECF) that surrounds the CNS cells; i.e. the CSF is in an 
expansion of the extracellular space (ECS), approximately 150 ml, which is filled with 
a type of "diluted" CNS ECF. 
OLDENDORF (1967) has reviewed the literature and presented the data which have 
been accumulated to advance the argument that the CSF circulating through the 
ventricles and in the subarachnoid space at the rate of 500 ml/day non-specifically 
clears solutes from the ECS of the CNS; i.e. the CSF constitutes a low-concentration 
compartment (a "sink") in widespread close contact with the CNS ECF. resulting in 
diffusion of solutes into the CSF. These solutes are then returned to the blood by 
bulk flow through the microtubular system of the arachnoid villi. It might be said 
that the sink action of the CSF serves the function of a lymphatic system adapted to 
the CNS. On the other hand, DAVSON AND SEGAL (1969) perfused the ventricles of 
rabbits with silicone instead of artificial CSF. The escape of [t4C]sucrose. an extra- 
cellular space marker, from the CNS was largely prevented by replacement of CSF 
by silicone. The data suggested that the removal of ions by a flow mechanism from 
the ECS was relatively unimportant, since the silicone should carry away the "sub- 
sidiary fluid" as efficiently as CSF. They suggested that the mechanism for escape of 
solutes from the CNS ECS to CSF is simple diffusion through a stationary ECF. 
The CSF is in contact with the ECS of  the CNS by the ependyma and possibly the 
Virchow-Robin spaces. The ependyma behaves like a loosely-knit membrane presum- 
ably with large gaps between its cells; moreover, according to BmGnTMAN ~ 1965) it is 
permeable to large molecules, e.g. ,  ferritin, 500,000 tool. wt. Aneasyexchange of sotutes 
across the ependyma could be related to the composition of MS CSF, since BROWNELL 
AND HUGHES (1962) have shown that 40~o of all the plaques of demyelination m 
chronic MS are located periventricularly. 
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The extent to which Virchow-Robin spaces follow small vessels is not settled; if 
they penetrate to at least the arteriolar level, they could offer a potential communica- 
tion between ECF and CSF in the subarachnoid space. 
Controversy over the size of the CNS ECS continues according to KAXZMAN (1968): 
is it 8, 13 or 18 % of the weight of the brain? The critical point is that there is an 
adequate amount of  ECS for the free diffusion of compounds. The relatively low 
inulin ECS found in dead animals by RALL et al. (1962), approximately 4-6 %, is very 
reminiscent of  the ECS estimated from electron micrographs. This suggests that at 
death cells within the CNS can swell and imbibe ECF. On the other hand, in plaques 
of  demyelination due to MS obtained at postmortem, PERIER AND GRI~GOIRE (1965) 
have presented electron micrographs which show an enlargement of  the ECS when 
compared to the surrounding normal-appearing white matter. The important point 
relative to MS is that the free movement of solutes between the CNS and CSF at least 
from the periventricular plaques of demyelination or those on the surface of the brain 
stem or spinal cord is not likely to be limited by the size of  the ECS. 
Many of the plaques of  MS are deep in the white matter. Are these plaques ac- 
cessible to the sink action of the CSF? Physical relationship of the CNS to the ventricles 
and subarachnoid space according to OLDENDORF (1967) reveals that there is no point 
which is more than 2 cm from the ependyma or pia. Most regions are within 1 cm and 
the parts of the CNS most likely to have plaques (periventricular surface, surface of 
the brain stem and spinal cord) are within a few mm. This arrangement of  CSF access 
to areas of  demyelination may be a factor in the high incidence of the CSF IgG value 
indicative of M S in patients who have a minimum degree of demyelination. 
On the other hand, all neurological physicians know that lumbar CSF can be normal 
in patients who eventually turn out to have MS. A complete answer to this enigma 
cannot be given; it will have to wait until we know more about the disease and its 
relationship to the CSF. Perhaps the size of the lesion and/or the distance from the 
CSF space could be a factor. Moreover, with 500 ml of  CSF formed per day an ab- 
normality could be diluted out. 
The activity of the lesion must be a factor. I t  is possible that a modestly active 
lesion produces too little of a substance to be detected in the fluid, e.g.,  lipids, lactic 
acid, enzymes, and immunoglobulin-G (IgG) ; or a lesion produces too small a change 
in the blood-CNS-CSF barrier so that the albumin and other serum proteins or 
constituents do not increase in the CSF. It is possible that anabolic or catabolic 
products of  the demyelinating lesions are metabolized by reactive cells. These cells 
may find their way to the perivascular spaces for removal via the blood more readily 
than via the fluid space. 
It goes without saying, based on the sink action theory of the CSF, that the discovery 
of the cause of MS will focus our attention on a search for it in the CSF or a tell-tale 
sign of its presence in the fluid. 
Finally, since the physiology of formation, circulation and absorption of CSF 
has not been studied adequately in MS patients we look forward to these data also. 
It is, however, reasonable to think that they will turn out normal, since the CSF 
pressure, Queckenstedt test, fall of CSF pressure with timed withdrawal of  fluid as 
well as reformation of CSF after withdrawal are normal (unpublished data). Further 
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the incidence and severity of post-lumbar-puncture headaches in MS patients does 
not differ from that in normal individuals (TOURTELLOTTE et al. 1964). 
ORIGIN OF CSF TOTAL PROTEIN 
It is generally accepted that most if not all CSF proteins in health originate from the 
serum except the trace proteins and some of the fi-globutins; they pass through a 
barrier which sets the protein content of CSF at approximately 1/200 that of the serum. 
The size of the molecule might be important since according to BURTIN (1964) all the 
proteins present in normal CSF have a molecular weight of no more than 160,000. 
KABAT et al. (1942), BURTIN (1960, 1964), McMENEMEV (1961), LATERRE (1965) and 
LUMSDEN (1965a) have shown that alterations in the composition of the protein 
components of serum are reflected in the CSF. In particular McMENEMEY (1961) 
found in myelomatosis that the serum protein elevations might relate to "typical" 
~-globulin and to ~2-globulin, but the principal increase may be in an abnormal 
fi-globulin fraction occupying an intermediary position between fl and 7- In each of 
the instances where these fractions of the serum proteins were increased in myeloma- 
tosis, MCMENEMEY found the same component disproportionately elevated in the 
CSF. 
Recent observations by FRICK (1960), CLAUSEN et al. (1964), LATERRE (1965) and 
CASPARY (1965) indicate that most if not all proteins based on immunoelectrophoretic 
characteristics in the serum and CSF are similar, which further supports the concept 
that the CSF protein is derived from serum. 
There are only 2 protein fractions spotted on zone electrophoresis utilizing various 
supporting media (paper, cellulose acetate paper and agar gel) which stand out in 
normal CSF when compared to serum. They are pre-albumin and flz-globulin (r- 
fraction). The origin of pre-albumin is probably in the blood. LATERRE (1965) has 
used various methods on the CSF and serum (ultracentrifugation, immunoelectro- 
phoresis, acrylamide and agar gel electrophoresis) as well as histo-immunofluorescence 
of the choroid plexus. They accumulated evidence that the pre-albumin in the serum 
was selectively concentrated by the choroid plexus in the process of secretion of CSF. 
The question of the origin of the r-fraction may also be solved. LM'ERRE (1965) 
concluded from reports available in the literature as well as from his own: personal 
studies that the r-fraction originates from serum transferrin; however, the serum 
transferrin has 4 more neuraminic acid groups than the CSF one. This alteration of the 
serum transferrin molecule changed the R I value on zone electrophoresis, but not its 
immunological characteristics. The removal of the 4 neuraminic acid groups from the 
serum transferrin molecules is the result of enzymatic hydrolysis by neuraminidase 
normally present in the nervous tissue; the hydrolysis is probably not the result of 
C SF neuraminidase. 
The origin of CSF fl-trace and 7'-trace globulins is still controversial; they are spotted 
when an antiserum to CSF is used with immunoelectrophoresis and at one time they 
were said to be specific CSF proteins. According to LATERRE (1965) and LINK (1967) 
these proteins with a molecular weight of < 30,000, are not found in theserum. They 
are found in extracts of CNS and urine but probably not in extracts of the kidney. 
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Supposedly because of their low molecular weight they diffuse easily throughout the 
body fluids from various tissue cells, such as from the CNS to the CSF. 
On the other hand, in MS and in several other diseases there is evidence which has 
been accumulated (TOURTELLOTTE AND PARKER 1968b) which suggests that the CNS 
is converted into an immunological organ capable of synthesizing IgG and anti- 
bodies. By diffusion through the ECF of the CNS from multifocal areas of synthesis, 
an elevated [gG in the CSF may reflect this newly-formed CNS protein. This thesis 
will be discussed in detail under a following section. 
CLAUSEN et al. (1964) revealed that immunoelectrophoretic investigation of the 
CSF utilizing antisera against normal serum can be used as a diagnostic tool. Normal 
CSF contains only serum proteins with a molecular weight less than 160,000. If a 
partial breakdown of the blood-CNS-CSF barrier occurs, this causes high molecular 
weight serum proteins to pass into the CSF compartment, for example, fibrinogen, 
~z-macroglobulin and IgM. 
The sites and rates of exchange of only 3 proteins, namely, albumin, IgG and [3- 
globulin between CSF, blood and CNS have been studied in health and disease in 
both animals and man. According to LUMSDEN (1965a) these 3 proteins account for 
most of the CSF protein in health or disease making up in normal CSF on the 
average 88 ~o, 58 ~ for albumin, 20 ~ for/3-globulin and l0 ~ for IgG. There is little 
question that in health both albumin and IgG are derived from the serum. The data 
to support this conclusion will be presented under following sections. 
FRICK AND SCHEID-SEYDEL (1960) studied intravenously-injected labeled serum 
fl-globulins in 20 patients with different diseases. When the dynamic equilibrium be- 
tween serum and CSF was established, it was found that the CSF specific activity was 
always less than in the serum. They interpreted these results to support the hypothesis 
that some of the CSF fl-giobulin is derived from the serum, but because an equilibrium 
of unity was not established it was necessary to postulate a non-labeled pool; presum- 
ably the CNS was contributing to the CSF fl-globulin. This hypothesis accords with 
the finding that the CSF normally contains a higher percentage of/3-globulin than 
that in serum and that CSF /3-globulin is partly made up of f12- or r-fraction, a 
neuraminic acid-deficient serum transferrin, not found in the serum. The passage of 
labeled fl-globulin was no different in 3 MS patients than in the other cases studied. 
On the other hand, an increase of the CSF proteins in disease might reflect not only 
degrees of change in the permeability of the blood-CNS-CSF barrier to serum protein, 
but also the local derivation of preformed or of newly-formed protein in the CNS. The 
degree of the change in the permeability of the blood-CNS-CSF barrier can be 
estimated by detecting an elevation of albumin in the CSF when the serum albumin 
level is not elevated and the flow of CSF is not blocked; hence, it can be a type of 
brain-CNS-CSF barrier test (see next section). On the other hand, the accumulation 
of excess IgG in the CSF can be the result of either a break of the barrier or the result 
of newly-formed protein in the CNS. Our group (TOURTELLOTTE AND PARKER 1965, 
1966a,b, 1967a, 1968a,b; TOURTELLOTTE el al. 1966, 1967, 1968) has presented data 
to support the hypothesis that there exists in the CNS of MS patients multifocal areas 
(the cell-type synthesizing IgG has not been identified) of synthesis of igG with 
resulting diffusion of the IgG into the CSF. Further, pre-formed proteins, such as 
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enzymes or lipoproteins which might be derived from diseased CNS cells possibly 
exist in MS CSF; but at most they contribute only trivial amounts to the total protein 
concentration. 
Data on the sites and rates of exchange of CSF proteins other than albumin, IgG 
and/3-globulin found in the CSF are not known; probably their concentration is set 
by rules which govern the blood-CNS-CSF barrier. On the other hand, according to 
DENCKER et al. (1961) a macromolecule such as fibrinogen, a non-CNS protein, when 
it appears in the CSF, certainly reflects a more extreme damage to the blood-CN S-CSF 
barrier than just an elevation of albumin which is a smaller molecule than fibrinogen. 
In summary then, from the standpoint of recent advances in the mechanisms which 
govern the concentration of CSF total protein in disease, it can be seen that we are 
not really interested in CSF total protein per  se, but in the various types of proteins 
which make up the total protein. Based on a multitude of reports in the literature and 
our own experience, it has become obvious that our focus of attention for the under- 
standing of the relationship of CSF to MS CNS lesions should be directed to the 
various proteins which constitute the total protein, especially albumin and IgG. 
Albumin concentration indicates the state of health of the blood-CNS-CSF barrier 
and an increase of IgG can do the same or reflect the existence of synthesis of IgG in 
the CNS. 
This section on the origin of CSF total protein is important because the total protein 
can reflect the state of health of the blood-CNS-CSF barrier. Further, a study of CSF 
total protein is also of importance since total protein serves as the basis for the most 
popular quotient, y-globulin as a percentage of total protein, which appears to reflect 
y-globulin synthesis in the CNS even when the blood-CNS-CSF barrier is damaged. 
ORIGIN OF C S F  ALBUMIN 
FISHMAN (1953), utilizing radio-active-labeled albumin, showed in dogs that there 
exists a dynamic equilibrium between blood and CSF albumin. FRICK ANt) SCHEID- 
SEYDEL (1958a) reported on the exchange of [13q]albumin between blood and CSF 
in man. A steady equilibrium of unity was obtained in 60 h in normal individuals as 
well as in patients with various diseases (meningoencephalitis, neurosyphilis, CNS 
tumors and MS). The fact that a steady equilibrium of unity was obtained in health 
with any of a large spectrum of CNS diseases, some of which had extensive damage 
to the blood-CNS-CSF barrier, e.g. tuberculous meningitis, proved that albumin 
originated exclusively from the blood. Moreover, their data supported the idea that 
the CSF albumin was removed from the CSF space via the blood. 
CUTLER et al. (1967a) also studied the origin of CSF albumin in man by following 
exchange of intravenously-injected 125I-labeled albumin between the blood and lumbar 
CSF in 17 patients. Patients with both normal and elevated CSF concentrations of 
total protein and albumin were included in the study. The relationship between blood 
and CSF specific activity indicated that CSF albumin was derived entirely from the 
blood albumin in all cases studied; the range of CSF albumin concentration was from 
10 to 1800 mg/100 ml. The effiux coefficient denoting the fractional daily removal of 
CSF albumin was found to remain constant over this wide range of CSF albumin 
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concentrations. On the other hand, the daily flux of albumin between plasma and 
CSF was found to vary directly with CSF albumin. Their data indicated that increased 
vascular permeability to albumin, rather than delayed removal from the CSF, was 
implicated in the pathogenesis of elevated CSF protein in their cases. The lack of 
dependency of the efflux coefficient upon CSF albumin concentration suggested that 
albumin was removed from the CSF compartment by a passive process that was not 
saturated by excess substrate. It was proposed that removal was accompanied by 
bulk flow through the arachnoid villi. 
CUTLER et al. (1970) also estimated the rate of flux of albumin into the entire CSF 
compartment during the ventriculolumbar perfusion of humans. The albumin influx 
was comparable in the control patients as well as in those with elevated IgG values 
(0.086-0.1 mg/min). 
To further support the hypothesis that CSF albumin is exclusively derived from the 
blood, let us turn to an elegant animal experiment. HOCHWALD AND WALLENSTEIN 
(1967a) studied the exchange of [13q]albumin between blood, CSF and CNS in the 
cat. When the [13q]albumin was given intravenously a steady-state of unity was 
accomplished between 4 and 20 h after injection. Because a steady-state value of 
unity was obtained in the CSF compared to the serum, this proved that all the CSF 
albumin arises from the blood. The reduction of CSF formation by acetazolamide 
(Diamox ®), a drug which has been shown to decrease the secretion of CSF at the 
choroid plexus, resulted in a decrease of albumin influx into the CSF. This result 
suggested that transfer of albumin from blood to CSF is only partially dependent 
(perhaps 40 G) on bulk fluid formation. Presumably 60 ~ of the CSF albumin enters 
from the surrounding CNS tissue. 
When the isotope was perfused through the ventricles it was removed by bulk 
absorption; presumably through the one way valvular microtubules in the arachnoid 
villi. Less than 0.1 G of the radioactivity could be recovered from the CNS. 
HOCHWALD (1970) also studied the influx of albumin to the spinal fluid along the 
neuraxis in cats. A difference of protein concentration between CSF obtained from 
the cisterna magna (27 mg/100 ml) and spinal subarachnoid space fluid (44 mg/100 
ml) was found in the cat, a gradient reminiscent of that which exists in man. His 
results indicated that the differences in CSF protein concentration along the neuraxis 
was not due to an increase of protein permeability into the spinal subarachnoid 
space. He stated that a reasonable explanation for the increased protein concentration 
in the spinal subarachnoid space was based on regional differences of CSF circulation 
(slower); it is due to the constant protein influx from the spinal cord in the ab- 
sence of CSF circulation which dilutes the protein which influxes from the CNS and 
transports it to the arachnoid villi for injection into the blood. 
Therefore, based on the above reports there is little doubt that CSF albumin is 
exclusively derived from the blood and is returned to it in both health and disease. 
It can be deduced from the studies presented above that the reasons for an increased 
CSF albumin are: (1) hemorrhage into the CSF space; (2) persistent elevated serum 
value since the CSF albumin equilibrates with it; (3) a lesion in the choroid plexus, 
since its secretion contains albumin; (4) damage of the blood-CNS barrier resulting 
in an increase of albumin in the CNS tissue which sets up a diffusion gradient so that 
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the excess albumin (and other serum proteins) sink into the CSF; and (5) blockage of 
the flow of CSF, particularly in the spinal subarachnoid space, which permits albumin 
which normally diffuses from the CNS tissue to accumulate because it is not washed 
away by the normal flow of CSF. 
In MS, a non-hemorrhagic disease (TOURTELLOTTE AND PARKER 1968b), the serum 
albumin concentration is normal (TOURTELLOTTE AND PARKER 1967). in MS there are 
no data to show, and there is no reason to believe, that the secretory mechanism of 
the choroid plexus is abnormal. Moreover, if there were blockage of  the flow of CSF 
in the spinal subarachnoid space this would be evidence against a diagnosis of un- 
complicated MS. Therefore, until proven otherwise, an increase of CSF albumin in 
MS is likely to be the result of a damaged blood-CNS barrier. 
TOURTELLOTTE AND PARKER (1967, 1968a,b) have proposed that the concentration 
of albumin in the CNS corrected for intravascular albumin is a type of evaluation of 
the blood-CNS barrier in MS, a non-hemorrhagic condition (TOURTELLOTTE AND 
PARKER 1968b). We proposed this endogenous test of the blood-CNS barrier primarily 
because of the above-mentioned isotope reports, but also because albumin is a non- 
CNS protein synthesized only in the liver; hence, there is no chance that the CNS could 
synthesize albumin and contribute it to the CNS extracellular and CSF space. Further, 
it is well known that the concentration of  serum albumin is a constant. For example, 
from our most recent data utilizing the immunochemical procedure of KABAT et al. 
(1948), 64 normal medical students had an average serum value of 4.64 g/100 ml 
(S.D. 0.458 and S.E.M. 0.058); whereas, in 54 MS patients the average value was 
4.55 (S.D. 0.660 and S.E.M. 0.09). Hence, the MS serum albumin is precisely regulated 
and determined with the same precision as in normal individuals. As a result, the CNS 
is constantly perfused by an albumin solution (blood) of known concentration, 
another factor of importance in establishing a steady state ratio between CSF and 
serum albumin. The ratio of the CSF to serum albumin turns out to be on the 
average 1:230 in normal individuals. Also it is necessary that the test substance 
of the blood-CNS barrier is not readily catabolized by the CNS. We have shown that 
human serum albumin added to homogenates of CNS is quantitatively recovered 
(ToURTELLOTTE AND PARKER 1966b). Moreover, incubation of CNS tissue up to 36 h 
postmortem revealed no change in the initial albumin concentration (unpublished 
data). Incidentally, similar results were obtained with IgG. Finally, the quantification 
of albumin with an antibody reagent is sensitive and specific (KABAT et al. 1948). 
Therefore, the determination of CSF albumin in an uncomplicated case of MS is a 
test of the blood-CNS-CSF barrier. 
it is possible to calculate the CSF albumin concentration based on data available 
in the literature obtained by various types of electrophoresis; however, the percentage 
of the total protein which is albumin as well as the total protein has to be given. It is 
not possible to deduce whether there is an elevation of albumin concentration in the 
CSF by inspection of the percentage distribution alone. For example, CSF specimens 
A and B could each have 50% of the total protein as albumin, both normal values. 
But if CSF specimen A contained 80 mg of total protein/100 ml and specimen B, 
40 mg, the concentration of albumin would be 40 and 20 rag/100 ml, respectively, 
Specimen A is abnormal and B is normal. 
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[n order to answer the question whether the blood-CNS-CSF barrier is abnormal 
in MS and how frequently, we will use data presented by KABAT et al. (1950) and data 
obtained at the University o f  Michigan Medical Center; both groups used the immuno- 
chemical method of KABAT et al. (1948). On the other hand, LUMSDEN (1965a) and 
LATERRE (1965) have surveyed the literature and composed tables to which the reader 
can refer, if it is desired to make a more thorough report by including the data obtained 
by various electrophoretic methods. 
According to KABAT et al. (1948) the normal average CSF albumin concentration 
(mg/100 ml) was 18.5 (S.D. 5.7). The upper limit of  normal was 29.9 (average + 2 S. D.). 
Our average value on 67 normal medical student volunteers (21-30 years old) was 
20.0 mg/100 ml (S.D. 7.3 and S.E.M. 0.89). Our upper limit of  normal was 34.5 
(average+2 S.D.). The data on males and females were combined since there was no 
statistical difference in the means (TOURTELLOTTE 1970). 
KABAT et al. (1950) found in 100 cases of MS that l case out of  78 with a normal 
total protein concentration, < 55 mg/100 ml (M + 2 S.D., P =  0.05) had a significantly 
elevated albumin concentration (TOURTELLOTTE 1970). However, when there was a 
significant elevation of the CSF total protein ( >55 mg/100 ml), 19 out of 22 or 8 6 ~  
of the cases had a significant elevation of the albumin concentration. The 3 cases 
which did not have an elevated albumin had < 65 mg/100 ml of total protein but 
> 55 mg/100 ml. 
Our group (TOuRTELLOTTE 1970) has confirmed the results of  KABAT et al. (1950). 
We found in 67 consecutive cases of MS that of  54 patients who had < 55 rag/100 ml of 
total protein, none had a significantly elevated albumin concentration. However, in the 
16 cases which had a significant elevation of the CSF total protein ( > 55 mg/100 ml) 
14 out of 16 or 88 ~o of the cases had a significant elevation of the albumin concentra- 
tion. The 2 cases which did not have an elevated albumin had < 60 mg/100 ml of 
total protein, but > 55 mg/100 ml. 
Since our data and those of KABAT et al. 1948, 1950) are so similar we have 
combined them in a plot (Fig. I). I t  shows a positive correlation between the albumin 
and total protein concentration. The correlation coefficient (r) was very high for the 
4 sets of data as well as overall. R values were 0.91, 0.92, 0.90, 0.89, and 0.88 for 
KABAT'S normal data, TOURTELLOTTE'S normal data, KABAT'S MS data, TOURTELLOTTE'S 
MS data and overall, respectively. 
If the degree of elevation of CSF total protein is a reflection of the extent of the 
damage to the blood-CNS-CSF barrier, it is our impression that the damage to the 
barrier is rarely extensive in MS. In our analysis of the CSF total protein 
(TOURTELLOTTE 1970) we found that 7 7 ~  of patients diagnosed as cases of MS on 
clinical grounds had a normal total protein and that 9 9 ~  of the group had a total 
protein value _< 108 rag/100 ml. Moreover, an acute worsening of the clinical condition 
less than 8 weeks prior to the CSF examination produced no further changes in the 
total protein and hence presumably no detectable change in the blood-CNS-CSF 
barrier. 
Experience has taught us that when the CSF total protein is more than 108 mg/100 
ml we should be on the look-out for another diagnosis. In the light of  the relationship 
of the CSF total protein to the blood-CNS-CSF barrier, it is reasonable to state that 
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an extreme decrease of the barrier is unusual in an uncomplicated case of MS; this 
declaration has also been proposed by LATERRE (1965). 
In summary, a significantly elevated CSF albumin concentration in MS is due to a 
decrease of the blood-CNS-CSF barrier. Based on this albumin test, about 2 0 ~  of 
MS patients have an abnormal barrier. When the albumin concentration in the CSF 
was abnormal, so was the total protein. In all cases when the total protein was 
> 65 mg/100 ml, the albumin was significantly elevated. It is reasonable to conclude 
from the high degree of correlation between the albumin and total protein concentra- 
tion of CSF (Fig. 1) that a significantly elevated total protein in MS reflects a decrease 
in the blood-CNS-CSF barrier. Accordingly, a CSF total protein determination 
is a convenient method for evaluation of the MS blood-CNS-CSF barrier. In the light 
of the extensive experience of other investigators (TOURTELLOTTE 1970) and of our 
own group with total protein concentrations in MS CSF we can conclude that a modest 
decrease in the barrier is found in approximately 23 ~ of MS patients (P=  0.05) and 
an extreme decrease of the barrier is unusual (P=  0.003). 
ORIGIN OF CSF AND CNS IMMUNOGLOBULIN-G(IgG) 
KABAT et al. (1942), LOWENTHAL (1964), BURTIN (1964), WIEME (1965), LATERRE 
(1965), LUMSDEN (1965a) and Davsoy  (1967) have included discussions of the origin 
of CSF immunoglobulins in health and various diseases. The following remarks give 
the historical perspective. Observations based on correlations of zonal electrophoretic 
patterns (Tiselius' free electrophoresis and supporting media of paper and various 
gels) as well as immunoelectrophoretic bands obtained on CSF and serum proteins 
leave no doubt that changes in the composition of serum v-globulins strongly in- 
fluences the CSF v-globulins. Further, these correlation studies leave only some doubt 
that the CSF ),-globulin under normal conditions is derived from the blood; in health 
the average serum: CSF [gG ratio is 1:300. On the other hand, in diseases such as 
neurosyphilis, MS, subacute sclerosing panencephalitis (SSPE) and several others, the 
data suggest that not all of the CSF v-globulin is derived from the blood. In these 
situations on the average the albumin: v-globulin ratio of the CSF is significantly 
lower than that of the blood and the percentage of v-globulin of the total protein 
was much higher than that in the serum. These data would suggest that some formation 
of v-globulin could take place within the tissues of the CNS and then the newly 
formed v-globulin could diffuse into the CSF, since 
permeability of the blood-CN S barrier which could 
without producing the same or an even greater 
molecule. 
it is difficult to imagine an altered 
produce an increase in v-globulin 
increase in the smaller albumin 
These speculations that v-globulin can be synthesized in the CNS have been put on 
sounder experimental grounds by utilizing radioactive-labeled albumin and IgG to 
trace the exchange between blood, CSF and CNS. 
The data presented by FRICK AND SCHEID-SEYDEL (1958b), are most important in 
regard to the origin of CSF IgG. 131I-labeled IgG was injected intravenously into a 
variety of patients. In those patients whose blood-CNS barrier was judged as normal, 
and who had a normal CSF IgG value, they found that the IgG penetrated into the 
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CSF more slowly than albumin, a steady state equilibrium of unity was established 
between the serum and CSF in 100 hours. Further, all the CSF igG was derived 
exclusively from the serum. Moreover, in those cases where there was an acute change 
in the blood-CNS-CSF barrier, e.g. ,  acute meningitis, all the CSF lgG was derived 
from the serum. On the other hand, 5 cases of MS with normal CSF total protein, that 
is, a normal blood-CNS-CSF barrier (see foregoing section), had an elevated CSF 
igG value. They found that 16-92~o of the CSF IgG was derived from some other 
source than serum--they suggested that it was produced locally in the CNS or its 
coverings. 
L1PPINCOTT et al. (.1965) have studied the passage of labeled lgG from the blood 
to the CSF and in the reverse direction in 21 MS patients. The average time a molecule 
of IgG spent in the CSF compartment was 17.3 h; whereas, in the blood compartment 
it was 72.4 h. Hence, the IgG in the CSF compartment was found to be replaced 4.2 
times as fast as it was in the blood compartment. In terms of recent advances in human 
CSF physiology (CUTLER e t  al. 1968; DAVSON 1967) this rapid turnover of CSF lgG 
was largely the result of drainage and corresponded to a renewal rate of 0.1 ~o per 
rain. The constant for penetration from the blood into the CSF was about 1,11 of this. 
Moreover, they stated that their transfer rate studies indicated that the total amount 
of lgG present in the CSF could not be accounted for solely as a result of physical 
transfer from the blood; their data confirmed that of FRICK AND SCHEID-SEYDEL 
(1958b). 
CUTLER et al. 0970) also injected intravenously radioactive albumin and 7-globulin 
(IgG) into 3 cases of MS, all with elevated IgG values. The data confirmed the earlier 
findings of FRICK AND SCHEID-SEYDEL (1958a,b) as well as those of LIPPINCOTT el a]. 
(1965). An apparent extravascular source of between 32 and 64 ~ of the CSF IgG in 
patients with MS, had to be postulated. On the other hand, the similarities of the 
albumin influx rates in all patients studied suggested that the serum was always the 
source of the CSF albumin. They concluded that in MS there was synthesis of lgG 
within the CNS and that a CNS pool o f l g G  contributed significantly to the CSF IgG 
of MS patients. 
Since BRIGHTMAN (1965) and RALL et al. (1962) have demonstrated diffusion of 
macromolecules between CNS and CSF, it would be anticipated that lgG, in high 
concentrations in the CNS could diffuse into the CSF. 
Experiments by CUTLER et al. (1967b) on patients with subacute sclerosing pan- 
encephalitis (SSPE), a disease which is characterized by an elevated CSF igG value, 
are germane for the hypothesis that the CN S is capable of becoming a type of immuno- 
logical tissue, i.e., capable of synthesizing IgG of which a fraction is antibody protein. 
In this study they attempted to define the origin of the excess lgG in CSF. They studied 
the exchange of IgG labeled with lZ~l between serum and CSF in 2 patients with 
SSPE and in 3 control patients with normal CSF IgG concentrations. In the control 
subjects, all the CSF lgG was derived from the serum; while in the 2 patients with 
SSPE only 13 and 32 ~ respectively was derived from the serum, a result reminiscent 
of that found in MS patients who had an excess of IgG in their CSF. The remainder 
of the CSF IgG originated from an unlabeled source, presumably through de novo 
synthesis in the CNS. 
.L neurol. Sci., 1970. 10:279 304 
CSF IMMUNOGLOBULIN-G(IgG) QUOTIENTS IN MULTIPLE SCLEROSIS 291 
Moreover, the flux of albumin and lgG into the CSF was measured during the 
ventriculolumbar perfusion of 8 patients with SSPE and 5 patients with brain stem 
tumors (controls). Total protein, albumin and IgG flux rates into CSF were linearly 
related to the concentration of these proteins in the CSF. In the patients with tumors 
the following mean values were obtained: total protein, 213 mg/day; albumin, 124 
mg/day; and IgG, 27 mg/day. Corresponding values in the patients with SSPE, all 
of whom had a marked elevation of CSF IgG value were: total protein, 363 mg/day; 
albumin, 144 mg/day; and IgG, 154 mg/day. While albumin entry rates were similar 
in both groups, the rate of IgG was increased six-fold. These observations provide 
quantitative data on the rate of turnover of albumin and IgG in CSF, and further 
support the concept that in certain neurological diseases IgG may be synthesized by 
cells within the CNS. 
To further support the hypothesis that the CSF IgG in health is exclusively derived 
from the blood, an elegant animal experiment by HOCHWALD AND WALLENSTEIN 
(1967b) should be included. They studied the exchange of 131I-labeled IgG between 
blood, CSF and brain in the cat. When radioactive IgG was administered intravenous- 
ly a steady-state of unity was obtained between 4 and 24 h. Because acetazolamide 
(Diamox ®), a known inhibitor of  CSF formation at the choroid plexus level, reduced 
the bulk fluid formation as well as the IgG influx, it was concluded that the transfer of 
lgG from blood to CSF was only partially dependent on bulk fluid formation by the 
choroid plexus. It was estimated that approx. 40 ~ of the CSF IgG in health derives 
from the choroid plexus. The rest of  the CSF lgG probably enters from the surround- 
ing CNS ECS which RALL et al. (1962) has shown to be in direct communication with 
the CSF. It is assumed that the origin of albumin and IgG in the ECS was from the 
blood across the very effective blood-CNS barrier; only 0.1 ~o of the labeled IgG 
could be recovered from the CNS when equilibrium was reached. In the cat approx. 
0.79 and 0.42/~g/min influx from the CNS to the CSF for albumin and IgG, respectiv- 
ely. During steady-state ventriculocisternal profusion, the labeled igG was cleared 
exclusively by bulk absorption of CSF; it was independent of protein concentration 
from 0.3 mg to 500 mg/100 ml. Under normal conditions these data on IgG are very 
similar to those that HOCHWALD AND WALLENSTEIN (1967a) found for albumin (see 
preceding section) except that the 24-h turnover for IgG was slower, approx, one-half 
that for albumin; presumably the larger IgG molecule, of 156,000 molecular weight, 
when compared to albumin, 40,000, is a factor in the slower turnover rate. 
These dynamic studies of FRICK AND SCHEID-SEYDEL, LtPPINCOTT et al.,  CUTLER 
et al. and HOCHWALD AND WALLENSTESN on CSF IgG utilizing radioactive tracers, 
taking into account their other data on albumin turnover, provide most impres- 
sive evidence supporting the hypothesis that the CNS in certain diseases, such as MS 
and SSPE, is capable of synthesizing a non-cerebral protein, namely IgG, which it 
does not do under normal circumstances. 
The question of selective transport or secretion of lgG from the serum to the CSF 
has been suggested as a mechanism to explain the elevated IgG in MS CSF (CASPARY 
1965). It is possible that a highly-selective filtration through the blood-CNS-CSF 
barrier tending to favor, for example, molecules of a certain size, shape and/or charge 
could allow an increase in the concentration of certain proteins in the CSF. It seems 
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to me that this possibility of selective transport of lgG across the blood-CNS-CSF 
barrier has been eliminated by the isotope studies of FRICK AND SCHEn}-SE'CDEt 
(1958b), L1PPINcO'rT et  al. (1965) and CUTLER et  al. (1967b, 1970). In control subjects 
and in those with a marked change in the barrier, e.g. ,  acute meningitis, the equi- 
valence of serum and CSF lgG specific activity at a time when CSF specific activity 
was maximal satisfied the criteria of a precursor-product relationship (Cu1 LER et al. 
1967b). Thus serum IgG was the immediate source of CSF IgG in these patients. By 
contrast, in patients with SSPE as well as in MS patients, the markedly-lower CSF 
specific activity at equilibrium indicated that only a small portion of the total CSF 
lgG was derived from serum. It would be an expected result if a selective transport 
of IgG across the blood-CNS-CSF barrier were the only mechanism, that the serum 
and CSF [gG specific activity ratio should be greater than unity. By contrast, if the 
blood-CNS-CSF barrier were damaged, the ratio should be unity, but not higher or 
lower. On the other hand, it is always possible that there exists a combination of 
leakage, selective transport and synthesis de novo contributing igG to the CSF IgG. 
Our interpretation of the CSF albumin data in MS patients (see section entitled 
ORIGIN OF CSF ALBUrvnN) indicated that in approx. 2 0 ~  of MS patients there is a 
modest decrease in the blood-CNS-CSF barrier. The fact is that in MS and SSPE at 
steady-state equilibrium of IgG (serum to CSF exchange) the ratio is less than 
unity; hence, a selective transport mechanism or damaged blood-CNS-CSF barrier 
cannot be the important mechanisms at work. Leakage and selective transport at most 
can only be contributing factors operating in the opposite direction lo the more 
powerful CNS synthesis of IgG. To explain the data it is necessary to conclude that 
the most important fountainhead of MS CSF IgG is that an extravascular pool of 
IgG, presumably lgG synthesized in the CNS is contributing IgG to the CSF IgG 
on top of a normal contribution from the blood. 
From the above reports we have been led to the conclusion that there exists in MS 
and SSPE an extravascular pool of [gG which is independent of the blood lgG 
but yet has ready access to the CSF. FRICK AND SCHEID-SEYDEL (1958b) suggested 
that the IgG originated from the CSF space which would include CSF cells, the 
covering membranes in contact with the CSF or the parenchyma of the CNS. KABAT 
et  al. (1948, 1950) and CUTLER et al. (1967b, 1970) suggested it arose de not, o in the 
CNS and diffused into the CSF. FIELD (.1954) postulated that accummulation of 
lymphoid tissue in the CNS may be the source of the locally-produced IgG. 
For some reason nobody had tested the CNS of MS and SSPE patients for increased 
IgG until 1964 when LOWE~qTrfAL (1964) made extracts of the CNS tissue and sub- 
jected them to agar gel electrophoresis. Gamma-globulins were usually detected in 
extracts made from CNS tissue with no obvious disease. On the other hand, extracts 
from MS or SSPE CNS tissue also obtained postmortem showed an excess of 7- 
globulins. He did not think that the increase of ),-globulin found was due to con- 
tamination by an excess amount of blood since the albumin concentration appeared 
to be within normal limits. 
TOURTELLOTTE AND PArtKER (1965, 1966a,b, 1967 and 1968a,b) and TOUR~rELLOTTE 
et al. (11966, 1967, 1968) also at about this time made a systematic study of post- 
mortem CNS tissue albumin and IgG in controls, as well as in cases of MS. The 
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techniques used to determine the IgG in the 0.15 M sodium chloride extracts were 
inspection of immunoelectropherograms, and the quantitative immunochemical 
technique of KABAT et  al. (1948). igG was elevated 3 times on the average in 11 of 
16 (69~)  postmortem MS brains (white matter and plaque) when compared to 10 
controls. Hypergammaglobulinemia, hyperemia, change in the blood-CNS-CSF 
barrier checked by bromide and albumin, or binding of igG to MS CNS tissue were 
not found to explain the elevated IgG in postmortem MS CNS. I t  was felt justifiable 
to conclude that most MS patients (probably active cases of MS) at the time of death 
have multifocal areas of  synthesis of IgG in the CNS. Utilizing a direct fluorescent 
technique to detect the localization of IgG,  SIMPSON et  al. (1969) have shown that the 
fluorescence was most concentrated at the edge of active plaques, it is reasonable to 
propose that the plaque edge which shows histological evidence of active demyelina- 
tion is a site for the synthesis of  CNS IgG. The actual cells involved in the synthesis 
have not yet been identified. Could they be a type of glial cell, mononuclear leucocyte, 
plasma cell, macrophage or all of  them? Other evidence has been presented to show 
that the high level concentration of IgG in the normal-appearing MS white matter 
and CSF is due to diffusion of IgG from a region of higher concentration. TOURTEL- 
LOTTE ANO PARKER (1966a) showed a positive correlation between the concentration 
of [gG in plaques of  demyelination due to MS as well as in normal-appearing white 
matter and the concentration of this globulin in the CSF. The tentative conclusion 
drawn from the results was that, in patients with MS, the increase in | g G  in the CSF 
is a reflection of an excess of  this globulin in the CNS. 
Because we (ToURTELLOTTE et  al. 1968) had such interesting results in 1 case of 
SSPE, a CNS disease due to rubeola, we published it. Since then we have studied 10 
other cases and all but one showed similar results. One of the characteristic features of  
SSPE is a prominent elevation of CSF IgG value in the presence of a normal serum 
igG. It seemed reasonable to conclude that the same mechanism was acting to explain 
the elevated CSF |gG in SSPE as it was in MS, i .e. ,  an increase of CSF IgG in the 
presence of normal serum IgG is a reflection of an excess of this globulin in the brain. 
The patient we reported was a classical case of SSPE. Moreover, laboratory ex- 
amination of the cerebral biopsy we studied revealed a myxovirus identified by 
electron microscopy and with fluorescent antibody measles reagent. The brain lgG 
was shown to be elevated by 2 methods: (a) inspection of immunoelectropherograms 
and (b) quantitative immunochemical determination of IgG (6.4 times increased) 
after correction for blood IgG. Utilizing albumin as a test agent to check the blood- 
CNS barrier, the increase of  | g G  was due in part to a decrease in the blood-CNS 
barrier. On the other hand, it was calculated that approximately 95 ~ of the CNS 
lgG arose from a source other than blood, presumably due to local synthesis in the 
CNS tissue. The measles antibody titer of  the CNS tissue extract was l : 80 and that of 
the serum was 1:16,384 (fluorescent measles antibody method). Based on the serum 
concentration in the CNS and the serum measles antibody titer, calculations revealed 
that the CNS antibody titer should have been at least 1:235. To explain the low 
observed CNS measles antibody titer we have postulated that the virus particles 
released from the CNS cells by homogenization neutralized the majority of  the extra- 
cellular measles antibodies. 
J. neurol. Sci., 1970, 10:279 304 
294 W. TOURTELLOFTE 
In summary, it can be concluded that in MS and SSPE it can be shown by several 
different methods (comparison of  serum and CSF lgG, exchange of radioactive- 
labeled IgG and albumin between serum and CSF as well as ventricutocisternal 
perfusion, fluorescent IgG and albumin tracing in the CNS, and immunoelectro- 
phoresis and quantitative immunochemical determination of lgG and albumin in 
CNS extracts), that there exists overwhelming evidence to support the hypothesis that 
the CNS can perform as an immunological tissue, i.e., it can synthesize IgG in MS 
and SSPE and in SSPE it can synthesize antibodies to measles virus as well as non- 
specific lgG. 
On the other hand, there are still experimental data missing which are needed to 
prove beyond reasonable doubt that the CSF IgG value can reflect that the MS CNS 
is performing like an immunological tissue, i.e. that it is synthesizing antibodies. 
First, what are the cells in the CNS tissue which do it? Can MS CNS tissue syn- 
thesize IgG in vitro? In order to establish that at least some of the lgG is antibody 
protein, it will be necessary to discover and isolate the antigen, for example, the 
virus or derivative of white matter which provokes the synthesis. 
In summary, the predominant characteristic of  the CSF profile indicative of MS 
is an elevation of its [gG value. Most MS patients have too much of this globulin in 
their body. Furthermore, it is a very special elevation, since it is compartmentalized 
to the CSF space and CNS tissue and little or no increase occurs in the blood. The 
question has arisen as to where this increased IgG originates? Data indicale that the 
fountainhead of [gG in health is exclusively the blood; whereas, when it is elevated in 
the CNS, unless there is a decrease in the blood-CNS barrier, or possibly hyper- 
gammaglobulinemia, it is synthesized in multifocal regions in the CNS, probably at 
the edge of active plaques of demyelination. After diffusion through the ECS of the 
CNS, the lgG sinks into the CSF which is circulating in the CSF space at the rate of 
500 ml/day. Finally, the enriched fluid is injected into the blood via the microtubules 
in the arachnoid villi. 
Since the same mechanism has been suggested to explain the elevation of CSF IgG 
value in SSPE it may be that whenever there is an elevation of the IgG value in the 
CSF there exists in the CNS synthesis of IgG. The difference from one disease to 
another when this tell-tale sign exists may be the antigen which triggers the CNS 
to produce IgG, some of which is antibody protein and the remainder non-specific 
lgG. Perhaps we should conclude that an elevated CSF IgG value (percentage of the 
total protein which is IgG) is indicative of synthesis of IgG in the CNS; in practice, 
if neurosyphilis is excluded, it turns out that MS is by far the most frequent cause of the 
CSF profile indicative of synthesis of IgG in the CNS. 
The question has arisen whether the CSF leucocytes in MS are capable of synthesiz- 
ing enough IgG to have an effect. A recent study by COHEN AND BANN~s~r~R (1967) 
included 1 patient with MS who had a lymphocyte count of 68/mm t~. The cells 
harvested from this patient synthesized immunoglobulins-G and -A, but not -M. They 
suggested that their data provided a direct demonstration that immunoglobulins-G 
and -A present in the CSF, were derived at least in part from cells within the CNS. 
Unfortunately, no controls were reported in order to determine if CSF leucocytes 
obtained from normal individuals or patients with other diseases had this potential. 
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COHEN AND BANNISTER inferred that the synthesis could be going on in the free floating 
CSF cells as well as in similar cells in the CNS. 
SANDBERG-WOLLHEIM et al. (1969) also studied synthesis in vitro of [gG by cells 
from the CSF in a patient with MS. They found evidence for synthesis of IgG during 
a relapse of the disease; however, IgG synthesis was just detectable when the CSF cells 
were obtained from the same patient in a remission. It was suggested that the CSF 
cells were antigenically stimulated when the patient was in a relapse, but not in 
remission. 
Can the circulating lymphocytes in the CSF account for the concentration of CSF 
IgG in MS? First, we need some basic information. According to FORBES AND 
HENDERSON (1966) human peripheral lymphocytes do synthesis IgG and the basal 
rate of secretion can be increased 2.4 times when stimulated with phytohemagglutinin 
which presumably provokes maximal stimulation of synthesis. HIRSCHHORN et al. 
(1963) calculated that 1 million lymphocytes stimulated by phytohemagglutinin pro- 
duced 10#g of l~gG in 24 h. 
In the average MS patient 20.8 ~ of the CSF total protein (48.5 mg/100 ml) is IgG 
(TOURTELLOTTE 1970); thus there is 10 mg IgG/100 ml CSF. A fraction of this IgG 
originates from the blood, i f  we assume no change in the blood-CNS-CSF barrier 
in the average MS patient, it isequal to that amount found in normal CSF. According- 
ly, in the average normal individual 9 .9~  of the CSF total protein (36.4 mg/100 ml) 
is lgG; i.e. there is 3.6 mg IgG/100 ml CSF. Hence, 6.4 mg IgG/100 ml is the calculated 
IgG which has to be accounted for by synthesis inside the blood CNS-CSF barrier. 
If 500 ml of CSF is formed per day then 32 mg of IgG is synthesized per day by the 
average MS patient. 
The average MS patient has 6 leucocytes mm 3 of CSF of which 90 ~ are lymphocytes 
(TOURTELLOTTE 1970); hence, there are on average 5.4 lymphocytes mm 3 or 
5.4 × l0 s lymphocytes/100 ml or 2.7 × 106 lymphocytes appearing in the circulating 
CSF per day. A million lymphocytes maximally stimulated can produce 10#g of IgG 
per day according to FORBES AND HENDERSON (1966). Hence 27#g could be synthesized 
by the lymphocytes which appear in the circulating CSF in a day or < 0.1 ~ of the 
32 mg to be accounted for. On the other hand, if tissue lymphocytes are responsible 
for the extra-lgG in MS, 3.2 billion lymphocytes would be needed which is a reason- 
able number. In summary, it can be said based on current knowledge regarding the 
ability of lymphocytes to synthesize and secrete IgG, that by calculation, circulat- 
ing MS CSF lymphocytes, even if maximally stimulated, could only account for 
< 0.1 ~ of the extra-IgG in the CSF per day .It is reasonable to assume that at least 
a fraction of the "cerebrogenic" IgG arises from tissue lymphocytes. Perhaps it is 
synthesized and secreted into the ECS of the CNS by a calculated 3.2 billion lympho- 
cytes per day and it then diffuses into the CSF. 
QUOTIENTS 
KABAT et al. (1948) found that the absolute concentration of CSF lgG (mg/100 ml) 
varied with the amount of total protein. Under preceding sections it was judged that 
an elevation of the CSF albumin was a reflection of the damage to the blood-CNS-CSF 
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barrier or blockage of  flow of CSF in the spinal subarachnoid space. Further, there 
was a remarkable correlation between the elevation of CSF albumin and total protein. 
This being so, it would be expected that the higher the total protein the more ex- 
tensive would be the transudation of the various serum proteins into the CSF, 
including lgG and in extreme conditions even macromolecules such as fibrinogen. It 
is of interest that KABAT et al. (1948), many years before a explanation o f  the mecha- 
nism was available, found that the absolute concentration of CSF lgG (rag/100 ml 
of CSF) varied with the amount of total protein, no matter which disease caused it. 
Further, they discovered when the results were expressed as a ratio of the total 
protein, there emerged a pattern which discriminated MS from most other diseases: 
i .e . ,  MS CSF had a significantly increased ratio. The reporting of CSF results as the 
fraction o f i g G  to the total protein expressed as a percentage is logically justified in the 
light of recent advances in CSF physiology and some new aspects of the pathology of 
MS. The quotient will normalize the increase of CSF IgG due to abnormal transuda- 
tion from the serum, since other proteins included in the total protein, e.g. ,  albumin, 
will increase in a proportional amount, no matter how extensive the blood-CNS-CSF 
barrier damage. On the other hand, the quotient of lgG: total protein would signal 
an extravascular source of IgG, presumably IgG synthesis de novo in the CNS, if an 
increased quotient was found. CSF albumin: CSF IgG ratio is a similar type of 
quotient and logically should be more discriminative than IgG : total prolein since the 
total protein includes the de novo synthesized IgG too. In fact we found that there 
really is not much difference: 73 ~ of  MS patients had an elevated quotient---practic- 
ally identical to the incidence, 67 ~ ,found when the quotient CSF lgG : CSF total 
protein was used (ToURTRLOTTE 1970). 
B~RGMANN et  aL (1964) and COSGROVE AND AGIUS (1966) utilized paper electro- 
phoresis to separate the CSF proteins; they found that 93 ~o of patients with MS had a 
decreased/J-globulin: v-globulin ratio. According to DENCK~R (1969) on the average 
the concentrations of/j-globulin are not changed in MS. On the other hand, the ?- 
globulin concentration in MS is frequently increased as may be the albumin value. 
So when the percentage distribution of the various protein fractions is calculated from 
the total densitometry reading, the ~o v-g lobulin fraction would be increased and the 
/J-globulin would have to be decreased. Consequently, the ratio of these two percent- 
ages would reflect a larger change in v-globulin, than would v-globulin expressed as a 
percentage of the total protein. Even though this quotient, when compared to others, 
is based on an artifact of calculation, its sensitivity merits its inclusion in this review. 
SCHINKO AND TSCHAmTSCHER (1959) as well as B~RGMANN et  al. (1964) expressed 
the changes in ~-globulin in terms of the quotient, CSF v-globulin: serum 7-globulin. 
They found that the quotient increased in MS. The increase in the ratio could be the 
result of y-globulin synthesized in the CNS which had diffused into the CSF and/or 
a change in the blood-CNS-CSF barrier with transudation of serum v-globulin into 
the CSF. Since this quotient does not separate out the transudation of 7-globulin into 
CSF across a damaged blood-CNS-CSF barrier, it is expected that this quotient would 
be abnormally increased in any patient with a damaged barrier; hence as they point 
out this decreases its usefulness in supporting the diagnosis of MS when the blood- 
CNS-CSF barrier is only slightly damaged as it is in 2 0 ~  of MS patients. Moreover 
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an elevation of CSF total protein is almost always combined with a diminished blood- 
CNS-CSF barrier function. The CSF protein pattern then becomes more like that of 
the serum, and the quotient loses its value as an index to distinguish between increased 
7-globulin derived by synthesis and diffusion across a damaged blood-CNS barrier. 
A FORMULA WHICH ESTIMATES THE AMOUNT OF IgG EXPRESSED IN mg ,  SYNTHESIZED PER 
DAY BY THE M S  C N S  
We have devised 
day by the CNS. 
if it occurs, is a 
assumed that for 
a calculation which yields the quantity of CSF IgG synthesized per 
The principle of the method is that the excess albumin in the CSF, 
quantitative marker of a damaged blood-CNS-CSF barrier. It is 
each mg of excess albumin that passes the damaged barrier from the 
blood, there is a proportional quantity of lgG which moves into the CSF. After 
determination of the excess CSF IgG and correcting for the amount that comes 
from the serum, we arrive at a value which, if it exceeds zero, reflects the synthesis of 
IgG in the CNS. Since 500 ml of CSF are formed and absorbed each day in normal 
man, and there is no reason to believe that the quantity is more or less in MS patients, 
we can calculate the amount o f l gG  made by the CNS each day. 
We shall first consider the application of the formula when the blood-CNS-CSF 
barrier is normal. A calculation to express the average amount of IgG synthesized by 
the CNS per day by an average MS patient is possible. Normally, 18.5 mg of tgG per 
day come from the blood [normal CSF IgG concentration is 3.7 mg/100 ml 
(ToURTELLOTTE 1970)] and 500 ml of CSF are formed and absorbed per day according 
to CUTLER et al. (1968). There is no reason to believe that this rate of formation of 
lgG which normally leaks across the blood-CNS-CSF barrier does not continue in 
MS patients, even when there is a neurogenic origin of  IgG. The average MS patient 
turns over 50 mg IgG/day [the average MS CSF IgG concentration is 10.0 mg/100 ml 
(TOURTELLOTTE 1970) and 500 ml of CSF are formed and absorbed per day]. If there 
is no change in the blood-CNS-CSF barrier in the average MS patient (this is a 
reasonable assumption in view of the average MS total protein of 48.5 mg per 100 ml 
and the albumin of 25.2, both within the normal limits), then the average MS patient's 
CSF [gG is made up of 3 7 ~  (18.5/50) of IgG derived from the blood and 6 3 ~  
(31.5/50) derived from synthesis de novo in the CNS. By direct measurement utilizing 
ventriculolumbar perfusion, CUTLER et al. (1967b) found in a more lethal condition, 
SSPE, 4 times the CNS synthetic rate that we have calculated for MS. However, we 
have had MS patients who by calculation have approached the rate they found in 
SSPE (Table 1). 
We shall now consider the usage of the formula where there is an abnormal blood- 
CNS-CSF barrier, i.e. an excess of albumin. Since our data agree reasonably well 
with those of KABAT et al. (1950) and since they have published the results on each 
case (their Table 3) we tested our method of calculation on their data, and found 
that it worked equally as well as on our own data. For example, KABAT'S Case 87 
had a total protein value of 69 rag/100 ml. The albumin concentration was 35 mg/100 
ml. The upper limit of normal albumin according to KABAT et al. is 30, So there was 
5 mg/100 ml of excess albumin. The normal serum lgG: albumin ratio according to 
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300 w. TOURTELLOTTE 
TOURTELLOTTE AND PARKER (1965) is 0.35. Accordingly, if 5 mg of albumin per 100 
ml passed from the serum to the CSF via the damaged blood-CNS-CSF barrier, then 
1.7 mg IgG/100 ml were derived from the serum (5 × 0.35) and should be subtracted 
from the CSF [gG concentration. The CSF IgG in Case 87 was 21 rag/100 ml; sub- 
traction of the upper limit of normal IgG, 6.5 mg/100 ml and the amount derived 
from transudation across the damaged blood-CNS-CSF barrier, 1.7, yields 12.8 mg 
igG/100 ml which is derived from some other source than the serum, presumably 
synthesized de novo in the CNS. Since 500 ml of CSF is made per day, in Case 87, 
64 mg of IgG was being made each day. This value is not unreasonable in the light 
of the data presented by CUTLER e/' al. (1967b). They found a value of 120 rng per day 
synthesized by the CNS in cases of SSPE when a direct measurement was made during 
the course of ventriculolumbar perfusion. 
In Case 87 it should be noted that the percentage IgG of total protein was also 
markedly abnormal, i.e. 3 0 ~ ;  their upper limit of  normal was 13'~ (P=0.05).  
Further, we found 8 l ~ of the cases to be abnormal with our sophisticated calculation 
and the IgG expressed as a percentage of total protein was abnormal in 79 ~ of the 
cases. The remarkable agreement between these two calculations should encourage 
the use of our formula to estimate the least amount of IgG, expressed in nag, syn- 
thesized per day by the MS CNS. 
Further refinement and individualization of the formula is possible. If the CSF 
lgG and albumin, as well as the serum values are known, it is possible to calculate the 
serum IgG: albumin ratio for a given patient. As a result, the normat serum lgG: 
albumin ratio, which, according to TOURTELLOTTE AND PARKER (1965) is 0.35, can be 
replaced in the formula for the one that the patient actually has. Therefore the effect 
of abnormally high or low serum albumin or IgG on the calculation of the excess 
CSF IgG which transudated from the serum into the CSF if a blood-CNS-CSF 
barrier existed could be more precisely adj usted. 
In Table l, we have presented data on 55 consecutive MS patients investigated so 
that the reader can try other types of analyses. The normal values obtained from 
college students aged 21-30 years are also presented. The average MS patient's 
CNS was found to be producing at least 16 mg IgG/day with a range of 0-100 mg. 
Our calculation by definition yields no synthesis in normal individuals since we have 
used mean + 2 standard deviation cut-off limits. Hence a calculated value > 0 is sig- 
nificant. 
It should be noted that this series of MS patients presented in Table 1 is similar to 
our larger series reported by my group elsewhere (TOURTELLOTTE 1970). This sample 
showed a higher percentage of MS patients with elevated IgG value in the CSF, i .e. ,  
80 ~o compared to our other larger sample, 67 ~ (TOURTELLOTTE 1970); [ believe this 
difference in incidence merely reflects a difference in sample size. The important point 
is that the percentage incidence of abnormal MS patients is the same for each of 2 
quotients presented, namely, CSF IgG as a percentage of total protein and CSF 
IgG as a percentage of albumin, as well as the percentage incidence of MS patients who 
showed any synthesis of IgG per day. 
Also of interest is that the least amount of IgG synthesized by an average MS patient 
per day in this series was 16 mg/day with a range of 0-100 mg/day. The total body 
J. neurol. Sci., 1970, 10:279-304 
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pool of IgG is 66 g which turns over at the rate of 7 ~ per day (JANEWAY et al. 1967). 
The maximum production by the MS CNS we found, 100 rag/day, could only add 
to it by 2 ~ .  Perhaps this is the explanation for the modest hypergammaglobulinemia 
found in some (20~)  of MS patients (TOURTELLOTTE 1970). Perhaps the quality of 
the IgG synthesized by the MS CNS and returned to the blood is more important than 
the quantity; i .e.,  antibodies to specific antigen, such as virus or white matter deriva- 
tives. 
COMMENTS 
TOURTELLOTTE (1970) has listed, based on clinical experience, the diseases which can 
produce an elevated CSF IgG value. In this report we have attempted to defend the 
hypothesis that an elevated CSF IgG value in MS is the result of a basic mechanism 
of the CNS which does not operate normally. IgG diffuses through the ECS of the 
CNS into the CSF from sites of synthesis of IgG in the CNS, but yet it is contained 
inside the blood-CNS-CSF barrier. It is possible for the synthetic mechanism to be 
operating very vigorously as it probably does in an active case of SSPE, or moderately 
as in active neurosyphilis, or modestly as it does in the average case of MS. It is 
possible that it stays "turned on" for a short time with self-limited viral infections 
such as poliomyelitis. It might continue to act as an immunological organ for pro- 
longed periods with slow infections, such as SSPE, subacute necrotizing encephalitis, 
neurosyphilis, and trypanosomal encephalitis. Furthermore, a damaged blood-CNS- 
CSF barrier could permit antibodies and leucocytes to enter the CNS more rapidly, 
but it would appear that this is an extreme reaction of short duration in MS, since 
the blood-CNS-CSF barrier is normal in 80 ~ of the cases and only modestly abnormal 
in the rest. More than likely most of the IgG synthesized in the CNS is not antibody 
protein. It may be that the concentration of non-antibody [gG in the ECS of the brain 
is part of a regulatory mechanism to slow down the CNS synthesis of IgG protein so 
that it will not become malignant. It  should be mentioned that this basic mechanism 
of the CNS to synthesize IgG is a defense mechanism, but it must be considered that 
endogenous antigens, such as derivatives of white matter might turn it on and hence 
it could destroy the CNS by autoclasia (LUMSDEN 1965b). For the autoimmune 
hypothesis to be realistic it would appear that the mechanism of removal of antigenic 
debris by lysosomal enzymatic hydrolysis, especially acid proteinases which readily 
hydrolyse basic protein of myelin, would have to be faulty in MS, which histopatho- 
logically does not appear to be the case. 
In our pursuit of the pathogenesis of MS, it is my impression that we have come 
upon a basic mechanism of the CNS which operates in a number of diseases which 
are infrequent enough and which are easily differentiated on clinical grounds from 
MS, so that the CSF IgG value becomes of some use in supporting the diagnosis of 
MS. 
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SUMMARY 
This review of the cerebrospinal fluid (CSF) changes in multiple sclerosis has brought 
together relevant recent advances in CSF physiology and some aspects of the patho- 
logy of MS as they relate to the CSF IgG quotients. 
A defense of the hypothesis that an elevated CSF IgG value in MS is the result of 
a basic mechanism of the CNS which does not operate normally, i.e., that IgG 
diffuses through the ECS of the CNS into the CSF from sites of synthesis of IgG in 
the CNS, but it is contained inside the blood-CNS-CSF barrier which is only ac- 
casionally slightly abnormal is presented. It is proposed that this basic mechanism 
underlies the elevated CSF IgG quotients (IgG/total protein and IgG/albumin): 
other diseases which induce the CNS to become an immunological organ, i .e. ,  to  
produce IgG, are clinically infrequent and are easily differentiated on clinical grounds 
from MS; thus the elevated CSF [gG quotient found in over two-thirds of the cases 
of MS becomes of value in supporting the diagnosis of MS. 
Finally, a formula is presented which estimates the amount of igG, expressed in 
mg, which is synthesized per day by the MS CNS. The average amount synthesized 
per day by a MS patient is 16 mg with a range of 0-100 mg. 
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